Status | Study |
Completed |
Study Name: Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors Condition: Kidney Cancer Date: 2009-10-29 Interventions: Genetic: DNA methylation analysis Genetic: |
Active, not recruiting |
Study Name: Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Condition: Adult Renal Wilms Tumor Beckwith-Wiedemann Syndrome Date: 2009-07-22 Interventions: Biological: Dactinomycin Given |
Completed |
Study Name: Gene Expression Profiles to Categorize Wilms Tumors Condition: Recurrent Wilms Tumor and Other Childhood Kidney Tumors Stage I Date: 2009-05-09 Interventions: Other: laboratory biomarker analysis Correlative studies |
Recruiting |
Study Name: Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies Condition: Wilms' Tumor Aniridia Date: 2007-07-17 Interventions: Behavioral: Questionnaire Ques |
Active, not recruiting |
Study Name: Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Condition: Stage III Wilms Tumor With Loss of Heterozygosity (LOH) for 1p and 16q Date: 2006-09-19 Interventions: Drug: doxorubicin hydrochloride |
Completed |
Study Name: Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Condition: Stage I Wilms Tumor Stage II Wilms Tumor Date: 2006-07-13 Interventions: Procedure: therapeutic conventional surgery |
Withdrawn |
Study Name: National Wilm's Tumor Study Late Effects Condition: Wilm's Tumor Date: 2005-09-27 Interventions: Other: none, screening only Screening protocol with no intervention |
Completed |
Study Name: A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor Condition: Wilms Tumor Date: 2005-09-12 Interventions: Drug: Topotecan, Filgrastim (G-CSF), Pegfilgrastim See detailed description section for additional detai |
Completed |
Study Name: WT1 Peptid Vaccination in Carcinomas Condition: WT1 Expressing Carcinoma Date: 2005-09-08 Interventions: Biological: WT1 126-134 peptide |
Completed |
Study Name: DNA Variations in the Gene in Young Patients With Wilms' Tumor Condition: Kidney Cancer Date: 2004-08-04 Interventions: Genetic: molecular genetic technique Genet |